Skip to content
PICO Portalanswers from OpenAlex

Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials

PaperCitations, authors & open-access status

Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials is a paper indexed in PICO Portal from OpenAlex.

How many citations does Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials have?

PICO Portalcitation count

Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials has 256 citations in the OpenAlex counts PICO Portal stores.

When was Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials published?

PICO Portalyear

Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials has 2012 year in the PICO Portal index.

What is the open-access status of Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials?

PICO Portaloa status

Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials has bronze oa status in the PICO Portal index.

What is the DOI of Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials?

PICO Portaldoi

The DOI for Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials is on the source record.

What is the PMID of Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials?

PICO Portalpmid

The PMID for Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials is on the source record.

What is the OpenAlex record for Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials?

PICO Portalopenalex

The OpenAlex for Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial